Website is intended for physicians
Всего найдено: 6



Article presents a clinical case of 83-year old woman with successful aspiration thrombectomy from the superior mesenteric artery due to its thromboembolism with the help of endovascular reperfusion catheter ACE68. Due to the satisfactory angiographic and clinical results - additional manipulations (artery stenting, selective thrombolysis) were not performed. Time from the onset of the disease to the restoration of blood mesenteric flow in the basin of the superior mesenteric artery was 24 hours, laparotomy or laparoscopy in post-operative period were not necessary. This article also discusses indications for endovascular treatment of acute occlusion of the superior mesenteric artery.



1.      Aboyans V., Ricco J.-B., M.-L. E.L. Bartelink, Bjorck M., Brodmann M., Cohnert T., Collet J.-Ph., Czerny M. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Endorsed by: the European Stroke Organization (ESO) The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). European Heart Journal. 2018; 39: 763-821.

2.      Bjorck M., Koelemay M., Acosta S. et al. Manage ment of the Diseases of Mesenteric Arteries and Veins. Clinical Practice Guidelines of the European Society of Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2017; 53: 460-510.

3.      Erben Y, Protack C.D., Jean R.A. et al. Endovascular interventions decrease length of hospitalization and are cost-effective in acute mesenteric ischemia. J Vasc Surg. 2018; 68 (2): 459 - 469.

4.      Karkkainen J.M., Manninen H., Paajanen H. Treatment options for acute mesenteric ischemia have improved. Duodecim. 2017; 132 (2): 150 - 158.

5.      Lawson R.M. Mesenteric ischemia. Crit Care Nurs Clin North Am. 2018; 30 (1): 29 - 39.

6.      Schermerhorn M.L., Giles K.A., Hamdan A.D. et al. Mesenteric revascularization: management and outcomes in the United States, 1988-2006. J Vasc Surg. 2009; 50 (2): 341-348.e1.

7.      Freitas B., Bausback Y, Schuster J. et al. Thrombectomy devices in the treatment of acute mesenteric ischemia: initial single-center experience. Ann Vasc Surg. 2018;51:124 - 131.

8.      Mendes B.C., Oderich G.S., Tallarita T. et al. Superior mesenteric artery stenting using embolic protection device for treatment of acute or chronic mesenteric ischemia. J Vasc Surg. 2018; S0741-5214 (18): 30276-3.

9.      Bala M., Kashuk J., Moore E.E. et al. Acute mesenteric ischemia: guidelines of the World Society of Emergency Surgery. World J Emerg Surg. 2017; 12: 38.

10.    Singh M., Long B., Koyfman A. Mesenteric ischemia: a deadly miss. Emerg Med Clin North Am. 2017; 35 (4): 879 - 888.

11.    Khripun A.I., Salikov A.V., Mironkov A.B., Pryamikov A.D. Endovascular interventions in the treatment of patients with acute mesenteric ischemia. Angiologiya i sosydistaya khirurgiya. 2017; 23 (4): 43-48 [In Russ].

12.    Shipovskiy V.N., Tsitsiashvili M.Sh., Juan C. et al. Rheolytic thrombectomy and stenting of the superior mesenteric artery in acute mesenteric thrombosis (case report). Angiologiya i sosydistaya khirurgiya. 2010; 16 (3): 49-54 [In Russ].

13.    Chen T.Y, Wu C.H., Hsu W.F. et al. Primary endovascular intervention in acute mesenteric ischemia performed by interventional cardiologists - a single center experience. Acta Cardiol Sin. 2017; 33 (4): 439-446.

14.    Kerzman A., Haumann A., Boesmans E. et al. Acute mesenteric ischemia. Rev Med Liege. 2018; 73 (5-6): 300-303.

15.    Bagdasarov V.V., Bagdasarova E.A. Acute intestinal occlusion in ischemic bowel disease. Almanakh Instituta khirurgii im. A.V. Vishnevskogo; 2018; 1: 222-223 [In Russ].

16.    Schegolev AA, Papoyan SA, Mitichkin A.E. et al. Endovascular treatment of acute mesenteric ischemia in thrombosis of the superior mesenteric artery. Angiologiya i sosydistaya khirurgiya; 2017; 23 (4): 50-54 [In Russ].

17.    Puippe G.D., Suesstrunk J., Nocito A. et al. Outcome of endovascular revascularisation in patients with acute obstructive mesenteric ischaemia - a single-center experience. Vasa. 2015; 44 (5): 363-370.

18.    Khripun A.I., Salikov A.V., Shurygin S.N. et al. Possibilities of endovascular surgery in the treatment of acute mesenteric ischemia. Angiologiya i sosudistaya khirurgiya. 2014; (2) 2: 68-77 [In Russ]. 



Lesions of the LCA stem are found in 2,5-4 % of patients with coronary heart disease who endured coronography, and are accompanied by more severe symptomatology, higher morbidity and mortality rates, and difficulty of radical correction. According to the generally accepted guidelines, the operation of coronary artery bypass has up to now been a method of choice in treatment of the LCA stem. Nevertheless, endovascular methods of treatment for LCA stem lesions have relatively long been used, while implementation into clinical practice of drug-eluding stents has considerably improved the remote outcomes, which made it possible to consider LCA stem stenting as a real alternative to ACB. Hence, the problem concerning indications for and contraindications to LCA stem stenting remains unsolved today. We retrospectively analysed a total of 75 endovascular interventions on the LCA stem in 67 patients, with an isolated lesion of the LCA stem being found only in 7,4 % of the patients. The remaining subjects had lesions of the LCA stem on the background of a multivascular lesion of the coronary bed, including occlusion of the RCA observed in 16,4 % of cases. Successive revascularization was performed in 98,64 % of cases, with no lethal outcomes. One patient required urgent ACB due to development of occluding dissection of the circumflex branch. Complications in the immediate postoperative period were observed in two patients and were represented by non-Q myocardial infarction and stroke. LCA stem stenting proved an efficient and safe method of treatment for coronary heart disease. A comparative analysis of the immediate results of LCA stem stenting and ACB revealed advantages of stenting, consisting in no lethal outcomes (in our series) and a lower short-term rate of postoperative complications.



1.     Cohen МУ Cohn PF, Herman MV, Gorlin R. Diagnosis and prognosis of main left coronary artery obstructtion. Circulation 1972; 45 (Suppl 1): 57 - 65.

2.     Gruentzig A.R. Transluminal dilatation of coronary artery stenosis. Lancet 1978; 1: 263.

3.     O'Keefe JH, Harztler GO, Rutherford BD, et al. Left main coronary angioplasty: early and late results of 127 acute and elective procedures. Am. J. Cardiol. 1989; 64: 144 - 147.

4.     Seung-Jung Park, MD, PHD, Young-Hak Kim, MD, Bong-Ki Lee, MD et al. Sirolimus-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Stenosis Comparison With Bare Metal Stent Implantation. Journal of the American College of Cardiology. 2005; 3 (45): 351-6.

5.     Seung-Jung Park, Young-Hak Kim, Bong-Ki Lee, Seung-Whan Lee, Cheol Whan Lee, Myeong-Ki Hong, Jae-Joong Kim, Gary S. Mintz, MD, Seong-Wook Park. Sirolimus-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Stenosis. J. Am. Coll. Cardiol. 2005; 45: 351-6.

6.     Colombo A, Moses JW, Morice MC, et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation. 2004; 109: 1244-9.

7.     Arampatzis CA, Hoye A, Saia F, et al. Elective sirolimus-eluting stent implantation for left main coronary artery disease: six-month angiographic follow-up and 1-year clinical outcome. Cathet. Cardiovasc. Interv. 2004; 62: 292 - 6.

8.     Joseph P. Ornato, Richard L. Page, Barbara Riegel etal. A Report of the American College of ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary. Circulation. 2006; 113: 156 - 175.

9.     Caracciolo EA, Davis KB, Sopko G, Kaiser GC et al. Comparison of surgical and medical group survival in patients with left main equivalent coronary artery disease: Long-term CASS experience. Circulation. 1995; 91: 2335-44.

10.   Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet. 1994; 344: 563 - 570.

11.   Park S, Hong M, Lee CW, et al. Elective stenting of unprotected left main coronary artery stenosis: effect of debulking before stenting and intravascular ultrasound guidance. J. Am. Coll. Cardiol. 2001; 38: 1054 - 1060.

12.   TakagiT, Stankovic G, Finci L, Toutouzas K, Chieffo A, Spanos У Liis-tro F, Briguori C, Corvaja N, Albero R, Sivieri G, Paloschi R, Di Mario C, Colombo A. Results and long-term predictors of adverse clinical events after elective percutaneous interventions on unprotected left main coronary artery. Circulation. 2002; 106: 698 - 702.

13.   Sorin J. Brener, MD; Bruce W Lytle, MD; Ivan P. Casserly, MD; Jakob P. Schneider, RN; Eric J. Topol, MD; Michael S. Lauer, MD. Propensity Analysis of Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Multivessel Coronary Artery Disease and High-Risk Features. Circulation. 2004; 109: 2290 -2295.

14.   Silvestri M, LefПvre T, Labrunie P, Khalife K, Bayet G, Morice MC, Bedossa M, Chmait A.. On behalf of the FLM registry investigators. The French registry of left main coronary artery treatment: Preliminary results. J. Am. Coll. Cardiol. 2003; 41: 45.

15.   Brigouri C, Sarais C, Pagnotta P, Airoldi F, et al. Elective versus provisional pumping in high-risk percutaneus transluminal coronary angioplasty. Am. Heart J. 2003; 145 (4): 700 - 7.

16.   Бокерия Л. А., Алекян Б. Г., Бузиашвили Ю. И. и др



Aim: was to assess dynamics of angiographic parameters of coronary artery rehabilitation, spasm throughout, below chronic coronary occlusion (CCO), after recanalization and balloon angioplasty, with survey of 8-10 weeks, basing on dynamics of anatomical and morphological characteristics of the artery with a major idea to optimize conditions for stenting.

Materials and methods: research analyzes results of two-stage treatment of 26 patients with CCO, complicated by a spasm, by which result after a recanalization of occlusion, was a contrasted artery with diameter less than 1 mm.

In these cases angioplasty with balloons with a diameter up to 3 mm doesn’t yield desirable results and diameter of an artery below a place of occlusion averaged 1,5 mm, and the difference of diameters of proximal and distally department averages 1,78 mm that is an adverse factor for stenting as is followed by high level of restenosis and thrombosis.

Results: within 4-8 weeks (on average 68 days) all arteries remained passable with equal contours, without angiographic signs of dissection, which took place right after balloon angioplasty Diameter of an artery increased with 1,5 mm to 2,64 mm; a difference of diameters of proximal and distally departments of an artery at the level of CCO decreased from 1,78 mm to 0,45 mm that was a favorable condition for stenting.

Conclusion: within 4-8 weeks after recanalization under normal pressure and blood flow occurs a readaptation of artery, expressed in a significant increase in the diameter of the artery below the CCO, which contributes to the optimization of stenting.



1.    Morino Y, Kimura T., Hayashi Y, Muramatsu T., Ochiai M., Noguchi Y, Kato K., Shibata Y, Hiasa Y, Doi O., Yamashita T., Morimoto T., Abe M., Hinohara T., Mitsudo K.; J-CTO Registry Investigators. In-hospital outcomes of contemporary percutaneous coronary intervention in patients with chronic total occlusion insights from the J-CTO Registry (Multicenter CTO Registry in Japan). JACC Cardiovasc Interv. 2010 Feb;3(2): pp. 143-51.

2.    Buller C.E., Dzavik V., Carere R.G., Mancini G.B., Barbeau G., Lazzam C., Anderson T.J., Knudtson M.L., Marquis J.F., Suzuki T., Cohen E.A., Fox R.S., Teo K.K. Primary stenting versus balloon angioplasty in occluded coronary arteries: the Total Occlusion Study of Canada (TOSCA). Circulation. 1999 Jul 20;100(3): pp. 236-242.

3.    Gould K.L. Coronary collateral function assessed by PET. In: « coronary artery stenosis and reversing atherosclerosis», Ed. By Gould KL,2-nd edition, New York, NY: Oxford University Press, 1999; pp. 275-282.

4.    Pixmeo company. Dr. Antoine Rosset, Prof. Osman Ratib and Joris Heuberger ( Geneva, Switzerland ), 2004;

5.    Okabe T., Mintz G.S., Buch A.N., Roy P, Hong YJ., Smith K.A., Torguson R., Gevorkian N., Xue Z., Satler L.F., Kent K.M., Pichard A.D., Weissman N.J., Waksman R. Intravascular ultrasound parameters associated with stent thrombosis after drug-eluting stent deployment. Am. J. Cardiol. 2007 Aug 15;100(4):615-20. Epub 2007 Jun 29.

6.    Costa M.A,, Angiolillo D.J., Tannenbaum M., Driesman M., Chu A., Patterson J., Kuehl W., Battaglia J., Dabbons S., Shamoon F., Flieshman B., Niederman A., Bass T.A.; STLLR Investigators. Impact of stent deployment procedural factors on long-term effectiveness and safety of sirolimus-eluting stents (final results of the multicenter prospective STLLR trial). Am. J. Cardiol. 2008 Jun 15; 101 (12): 1704-11. doi: 10.1016/j.amjcard.2008.02. 053. Epub 2008 Apr 9.

7.    Hong M.K., Mintz G.S., Lee C.W., Park D.W., Choi B.R., Park K.H., Kim YH., Cheong S.S., Song J.K., Kim J.J., Park S.W., Park S.J. Intravascular ultrasound predictors of angiographic restenosis after sirolimus-eluting stent implantation. Eur. Heart J. 2006 Jun;27(11):1305-10.

8.    Werner G.S., Jandt E., Krack A., Schwarz G., Mutschke O., Kuethe F., Ferrari M., Figulla H.R. Growth factors in the collateral circulation of chronic total coronary occlusions: relation to duration of occlusion and collateral function. Circulation Oct. 2004; 110(14): pp. 1940-1945.

9.    Sakurai R.L., Ako J., Morino Y, Sonoda S., Kaneda G., Terashima M., Hassan A.H., Leon M.B., Moses J.W.. Popma J.J., Bonneau H.N., Yock PG., Fitzgerald PJ., Honda Y. Predictors of edge stenosis following sirolimus-eluting stent deployment (a quantitative intravascular ultrasound analysis from the SIRIUS trial). SIRIUS Trial Investigators. Am. J. Cardiol. 2005 Nov 1;96(9):1251-3. Epub 2005 Sep 6.

10.  Cosby R.S., Giddings J.A., See J.R. Coronary collateral circulation. Chest Jul. 1974; 66(1): pp. 27-31.

11.  Kathryn Maiellaro, W. Robert Taylor. The role of the adventitia in vascular inflammation. Cardiovascular Research 2007 Sep 1;75(4): pp. 640-8.



The world data devoted to endovascular treatment of acute thrombotic or thromboembolic occlusion of the superior mesenteric artery are provided in article. Various methods of intra vascular interventions are described at acute mesenteric ischemia: mechanical and rheolytic thrombectomy, retrograde stenting, thrombolytic therapy and some others. Endovascular intervention, according to different authors, may consider as choice option in treatment of patients in a stage of intestine ischemia.



1.     Cho J.S., Carr J.A., Jacobsen G. et al. Long-term outcome after mesenteric artery reconstruction: a 37-year experience. J. Vasc. Surg. 2002; 35(3):453-460.

2.     Kougias P., Lau D., El Sayed H.F. et al. Determinants of mortality and treatment outcome following surgical interventions for acute mesenteric ischemia. J. Vasc. Surg. 2007;46(3): 467-474.

3.     Park W.M., Gloviczki P., Cherry K.J. et al. Contemporary management of acute mesenteric ischemia: factors associated with survival. J. Vasc. Surg. 2002; 35(3): 445-452.

4.     Sreedharan S., Tan YM., Tan S.G. et al. Clinical spectrum and surgical management of acute mesenteric ischaemia in SingaporeSingapore Med. J. 2007; 48(4): 319-323.

5.     Lepedat P. Infarkt kishechnika[Mesenteric necrosis]. Medicinskoe izdatel'stvo, Buharest. 1975; 282 s [In Russ].

6.     Савельев В.С., Петухов В.А., Сон Д.А. и соавт. Новый метод энтеросорбции при синдроме кишечной недостаточности. Анналы хирургии. 2005; 1; 29-32. Savel'ev V.S., Petuhov V.A., Son D.A. i soavt. Novyj metod jenterosorbcii pri sindrome kishechnoj nedostatochnosti [New method of enterosorbtion in acute mesenterial insufficiency]. Annaly hirurgii. 2005; 1; 29-32 [In Russ].

7.     Szabуnй Rйvйsz E. Acute mesenteric ischemia: analysis of cases admitted to a hospital during 10 years (2001-2010). Orv. Hetil. 2012;153(36):1424-1432.

8.     Corcos O., Castier Y, Sibert A. et al. Effects of a Multimodal Management Strategy for Acute Mesenteric Ischemia on Survival and Intestinal Failure. Clin. Gastroenterol. Hepatol. 2012;11(2):158-165.

9.     Markovich O.V., Shkodivskij N.IMorfofunkcional'nye izmenenija v stenke tonkoj kishki pri vremennom narushenii arterial'nogo krovoobrashhenija[Morphologic-functional changes in intestinal wall at temporary disorders of mesenterial blood circulation. Anatomija ta operativna hirurgija. 2005;4(1):12-15[In Russ].

10.   Pokrovskij A.V., Judin V.IOstraja mezenterial'naja neprohodimost'. Klinicheskaja angiologija: rukovodstvo pod red. Pokrovskogo A.V. [Acute mesenterial obstruction.] V 2-h tomah. Tom 2. M.: Izdatel'stvo «Medicina». 2004; 626-645[In Russ].


11.   Marston A. Sosudistye zabolevanija kishechnika. Patofiziologija, diagnostika i lechenie [Vascular diseases of bowel. Pathophysiology, diagnostics and treatment.]. M.: «Medicina».1989; 304 s [In Russ].

12.   Gol'dgammer K.K. Ostryj zhivot pri trombozah i jembolijah verhnih bryzheechnyh sosudov[«Acute abdomen» in thrombosis and embolism in superior mesenteric vessels]. M.: Medicina. 1966;184 s[In Russ].

13.   Давыдов Ю.А. Инфаркт кишечника и хроническая мезентериальная ишемия. М.: Медицина. 1997; 208 с. Davydov Ju.A. Infarkt kishechnika i hronicheskaja mezenterial'naja ishemija []. M.: Medicina. 1997; 208 s[In Russ].

14.   Savel'ev V.S., Spiridonov I.VOstrye narushenija mezenterial'nogo krovoobrashhenija[...]. M.: Medicina. 1979; 232 s[In Russ].

15.   Pokrovskij A.V., Belojarcev D.FIstorija hirurgii torakoabdominal'nogo otdela aorty i ego vetvej v Rossii [History of surgery of thoracic and abdominal aorta and its brunches]. Materialy 13 vserossijskogo s'ezda serdechno-sosudistyh hirurgov, Moskva. 25-28 nojabrja 2007; 368-369[In Russ].

16.   Shipovskij V.N., Ciciashvili M.Sh., Huan  Ch. I soavt. Reoliticheskaja trombjektomija i stentirovanie verhnej bryzheechnoj arterii pri ostrom mezenterial'nom tromboze (klinicheskoe nabljudenie) [Rheolytic thrombectomy and stenting of superior mesenteric artery in acute mesenterial thrombosis (case report)]. 



Article presents data of modern literature concerning diagnostic efficiency of computed tomography and CT-angiography in diagnostics of acute disorders of mesenterial blood circulation. Article describes various groups of instrumental diagnostic signs indicating directly or indirectly on acute thrombotic and thromboembolic occlusion of mesenterial.

According to huge ammount of authors, CT-angiography can be considered as the first step in instrumental diagnostics of acute disorder of mesenterial blood circulation, due to demonstrated sensitivity and specificity, comparable in comparison with a standard angiography. 



1.     Pokrovskij A.V., Judin V.I. Ostraja mezenterial'naja neprohodimost'. Klinicheskaja angiologija: rukovodstvo pod redakciej Pokrovskogo A.V[Acute mesenterial obstruction. Clinical angiology: Manual, edited Pokrovskij A.V.]. V 2-h t. M.: Medicina. 2004; 2: 626-645 [In Russ].

2.     Burns B.J., Brandt L.J. Intestinal ischemia. Gastroenterol. Clin, North Am. 2003; 32 (4): 1127-1143.

3.     Cho J.S., Carr J.A., Jacobsen G. et al. Long-term outcome after mesenteric artery reconstruction: a 37-year experience. J. Vasc, Surg, 2002; 35 (3): 453-460.

4.     Oldenburg W.A., Lau L.L., Rodenberg T.J. et al. Acute mesenteric ischemia: a clinical review. Arch, Intern, Med, 2004; 164 (10): 1054-1062.

5.     Wang J.Y., Cheng K.I., Yu F.J. et al. Analysis of the correlation of plasma NO and ET-1 levels in rats with acute mesenteric ischemia. J. Invest. Surg. 2006; 19 (3): 155-161.

6.     Mamode  N., Pickford I., Leiberman P. Failure to improve outcome in acute mesenteric ischaemia: seven-year review. Eur. J. Surg. 1999; 165 (3): 203-208.

7.     Corcos O., Castier Y., Sibert A. et al. Effects of a Multimodal Management Strategy for Acute Mesenteric Ischemia on Survival and Intestinal Failure. Clin, Gastroenterol. Hepatol. 2012; 11 (2): 158-165.

8.     Ryer E.J., Kalra M., Oderich G.S. et al. Revascularization for acute mesenteric ischemia. J. Vasc. Surg. 2012; 55 (6): 1682-1689.

9.     Ozturk G., Aydinli B, Atamanalp S.S. et al. Acute mesenteric ischemia in young adults. Wien. Med. Wochenschr. 2012; 162 (15): 349-353.

10.   Schoots I.G., Koffeman G.I., Legemate D.A. et al. Systematic review of survival after acute mesenteric ischaemia according to disease aetiology. Br. J. Surg. 2004; 91 (1): 17-27.

11.   Zelenkov N.P., Mel'janov A.V., Esikov Ju.V. i soavt. Uspeshnoe hirurgicheskoe lechenie ostrogo narushenija mezenterial'nogo krovoobrashhenija [Successful surgical treatment of acute mesenterual blood circulation]. Materialy Mezhdunarodnogo hirurgicheskogo kongressa «Novye tehnologii v medicine». Rostov-na-Donu. 2005; 379 [In Russ].

12.   Savel'ev V.S., Petuhov V.A., Son D.A. i soavt. Novyj metod jenterosorbcii pri sindrome kishechnoj nedostatochnosti. [New method of internal absorbtion in patients with intestinal insufficiency] Annalyhirurgii. 2005; 1: 29-32 [In Russ].

13.   Murray S.P., Ramos T.K., Stoney R.J. Surgery of coliac and mesenteric arteries. In.: Enrico Ascher ed. Hamovici's Vascular Surgery, 5th edition. Blackwell Publishing. 2004; 72: 861-874.

14.   O'Mahony G.D., Gallucci M.R., Cordova-Fraga T. et al. Biomagnetic investigation of injury currents in rabbit intestinal smooth muscle during mesenteric ischemia and reperfusion. Dig. Dis. Sci. 2007; 52 (1): 292-301.

15.   Pompermayer K., Amaral F.A., Fagundes C.T. et al. Effects of the with glibenclamide, an ATP-sensetive potassium channel blocker, on intestinal ischemia and reperfusion injury. Eur. J. Pharmacol. 2007; 556 (1): P. 215-22.

16.   Kassahun W.T., Schulz T., Richter O. et al. Unchanged high mortality rates from acute occlusive intestinal ischemia: six year review. Langenbecks Arch. Surg. 2008; 393 (2): 163-171.

17.   American Gastrointestinal Association Medical Position Statement: guidelines on intestinal ischemia. Gastroenterology, 2000; 118: 951-953.

18.   Duber C., Wustner M., Diehl S.J. et al. Emergency diagnostic imaging in mesenteric ischemia. Chirurg. 2003; 74 (5): 399-406.

19.   Lock G. Acute mesenteric ischemia: classification, evaluation and therapy. Acta Gastroenterol, Belg, 2002; 65 (4): 220 - 225.

20.   Park W.M., Gloviczki P., Cherry K.J. et al. Contemporary management of acute mesenteric ischemia: factors associated with survival. J. Vasc, Surg, 2002; 35 (3): 445-452.

21.   Van Beers B.E., Danse E.M. Vascular lesions of the liver and gastrointestinal tract. Acta Gastroenterol. Belg. 2002; 65 (4): 226-229.

22.   Kortmann B., Klar E. Recognizing acute mesenteric ischaemia too late: reasons and diagnostic approach from a surgical point of view. Zentralbl. Chir. 2005; 130 (3): 223 - 226.

23.   Staib L. Intestinal ischemia - surgeon's view. Schweiz. Rundsch. Med. Prax. 2006; 95 (44): 1717-1721.

24.   Ataev S.D., Abdullaev M.R., Ataev D.S. Ostrye narushenija mezeneterial'nogo krovoobrashhenija [Acute mesenterial blood circulation disorders]. Materialy Mezhdunarodnogo hirurgicheskogo kongressa «Novye tehnologii v medicine». Rostov-na-Donu. 2005: 378 [In Russ].

25.   Savel'ev V.S., Spiridonov I.V., Boldin B.V. Ostrye narushenija mezenterial'nogo krovoobrashhenija. Infarkt kishechnika [Acute mesenterial blood circulation disorders. Intestinal infarction.]. Rukovodstvo po neotlozhnoj hirurgii pod redakciej Savel'eva V.S. M.: Triada H. 2005; 281-302 [In Russ].

26.   Alhan E., Usta A., Cekic A. et al. A study on 107 patients with acute mesenteric ischemia over 30 years. Int. J. Surg. 2012; 10 (9): 510-513.

27.   Hellinger J.C. Evaluating mesenteric ischemia with multidetector-row CT angiography. Tech. Vasc. Intev Radiol, 2004; 7(3): 160-166.

28.   Horton K.M., Fishman E.K. Multidetector CT angiography in the diagnosis of mesenteric ischemia. Radiol, Clin, North. Am. 2007; 45: 275-288.

29.   Shih M.C., Angle J.F., Leung D.A. et al. CTA and MRA in mesenteric ischemia: part 2, Normal findings and complications after surgical and endovascular treatment. Am. J. Roentgenol. 2007; 188 (2): 462-471.

30.   Smerud M.J., Johnson C.D., Stephens D.H. Diagnosis of bowel infarction: a comparison of plain films and CT scans in 23 cases. Am. J. Roentgenol. 1990; 154: 99-103.

31.   Turkbey B., Akpinar E., Cil B. et al. Utility of multidetector CT in an emergency setting in acute mesenteric ischemia. Diagn. Interv. Radiol. 2009; 15 (4): 256-261.

32.   Menke J. Diagnostic accuracy of multidetector CT in acute mesenteric ischemia: systematic review and meta-analysis. Radiology. 2010; 256 (1): 93-101.

33.   Zalcman M., Sy M., Donkier V. et al. Helical CT sings in the diagnosis of intestinal ischemia in small-bowel obstruction. Am. J. Roentgenol. 2000; 175: 1601-1607.

34.   Zandrino F., Musante F., Gallesio I. et al. Assessment of patients with acute mesenteric ischemia: multislise computed tomography sings and clinical performance in a group of patients with surgical correlation. Minerva Gastroenterol. Dietol. 2006; 52 (3): 317-325.

35.   Arroja B., Canhoto C., Silva F. et al. Acute mesenteric ischemia. Rev. Esp. Enfem. Dig. 2010; 5: 327-328.

36.   Ha H.K., LeeS.H., Rha S.E. et al. Radiologic features of vasculitis involving the gastrointestinal tract. Radiographics. 2000; 20: 779-794.

37.   Rosow D.E., Sahani D., Strobel O. et al. Imaging of acute mesenteric ischemia using multidetector CT and CT angiography in a porcine model. J. Gastrointest. Surg. 2005; 9 (9): 1262 - 1274.

38.   Johnson J.O. Diagnosis of acute gastrointestinal hemorrhage and acute mesenteric ischemia in the era of multi-detector row CT. Radiol, Clin, North Am. 2012; 50 (1): 173-182.

39.   Yikilmaz A., Karahan O.I., Senol S. et al.. Value of multislice computed tomography in the diagnosis of acute mesenteric ischemia. Eur. J. Radiol. 2011; 80 (2): 297-302. 




Aim: was to estimate parameters of left ventricle (LV) perfusion and kinetics at ischemic chronic heart failure (CHF), which initial values are predictors of increased myocardial functional reserve and patients clinical status improvement as a result of revascularization.

Materials and methods: examined 157 patients (146 men and 11 women; age from 33 to 72 years) before and in 2 - 3 days after percutaneous coronary intervention with diagnosis: CAD, CHF with NYHA class III-IV echocardiography parameters of LV: ejection fraction less than 40%, end-diastolic volume is more than 200 ml. Perfusion and function disorders were estimated with use of ECG-gated single photon emission computed tomography (SPECT).

Results: in 48% of cases 6-minute walk test increased more than 150%; NYHA class decreased by 2 classes (group 1). In 52% cases 6-minute walk test increased less than 50% and the NYHA class decreased on 1 class or did not change (group 2). Comparison of initial LV condition and clinical effect revealed following conformities. The revascularization effect is limited not to extent of coronary blood flow recovery, but first of all a cardiac muscle condition, the quantitative relation of the functioning myocardium and a focal cardiosclerosis. Thus, critical size to define the favorable forecast of revascularization is perfusion disorder more than a half of LV and kinetics disorder more than a third of cardiac muscle volume. Prevalence of a cardiosclerosis over the functioning myocardium limits clinical effect of a revascularization and growth of a functional reserve.

Conclusion: degree of initial LV myocardium perfusion and movement disorders at patients with severe ischemic heart failure is the key indicator, influencing clinical efficiency of coronary intervention



1.     Ageev F.T., Belenkov Yu.N., Fomin I.V., et al. Rasprostranennost hronicheskoj serdechnoj nedostatochnosti v Evropejskoj chaste Rossijskoj Federacii - dannye JEPOHA-HSN [The prevalence of chronic heart failure in the European part of the Russian Federation - Data AGE-CHF]. Serdechnaya nedostatochnost. 2006;7(1):112-115 [In Russ].

2.     Bax J.J., Delgado V. Myocardialviability as integral-part of the diagnostic and therapeutic approach to ischemic heart failure. J Nucl Cardiol. 2015 Apr;22(2): 229-45.

3.     Mareev V.Yu., Danielyan M.O., Belenkov Yu.N., Ot imeni rabochej gruppy issledovaniya JEPOHA-O-HSN. Sravnitelnaya harakteristika bolnyh s HSN v zavisimosti ot velichiny FV po rezultatam Rossijskogo mnogocentrovogo issledovaniya JEPOHA-O-HSN [On behalf of the working group study AGE-O-CHF. Comparative characteristics of patients with CHF, depending on the size of the PV on results of Russian studies mnogotsentrovogo AGE-O-CHF]. Serdechnaya nedostatochnost. 2006;7 (4):164-171 [In Russ].

4.     Samady H., Elefteriades J.A., Abbott B.G., et al. Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome. Circulation. 1999;100:1298- 304.

5.     Patel H.C., Ellis S.G.Role of revascularization to improveleft ventricular function. Heart Fail Clin. 2015 Apr; 11(2):203-14.

6.     Yancy C.W., Jessup M., Bozkurt B., et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary. J Am Coll Cardiol 2013;62:1495-539.

7.     McMurray J.J., Adamopoulos S., Anker S.D., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33:1787-847.

8.     Fonseca C., Morais H., Mota T., Matias F., Costa C., Gouveia-Oliveira A., Ceia F. EPICA Investigators. The diagnosis of heart failure in primary care: value of symptoms and signs. Eur J Heart Fail. 2004 Oct; 6(6):795-800, 821-2.

9.     Shabana A., El-Menyar A. Myocardial viability: what we knew and what is new. Cardiol Res Pract. 2012; 2012:607486.

10.   Ling L.F., Marwick T.H., Flores D.R., Jaber W.A.. Brunken R.C., Cerqueira M.D., Hachamovitch R.Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardium. Circ Cardiovasc Imaging. 2013 May 1;6(3):363-72.

11.   Schinkel A.F., Poldermans D., Rizzello V., Vanoverschelde J.L., Elhendy A., Boersma E., Roelandt J.R., Bax J.J. Why do patients with ischemiccardiomyopathy and a substantialamount of viablemyocardium not always recover in function after revascularization? J Thorac Cardiovasc Surg. 2004 Feb;127(2):385-90.

12.   Mandegar M.H., Yousefnia M.A., Roshanali F., Rayatzadeh H., Alaeddini F. Interaction between two predictors of functional outcome after revascularization in ischemic cardiomyopathy: left ventricular volume and amount of viable myocardium. J Thorac Cardiovasc Surg. 2008 Oct; 136(4):930-6.

13.   Beanlands R.S.B., Dawood F., Wen W.H. et al. Are the kinetics of technetium 99m-methoxy isobutyl isonitrile affected by cell metabolism and viability? Circulation. 1990; 82:1802-1814.

14.   Rizzello V., Schinkel A.F., Bax J.J., et al. «Individual prediction of functional recovery after coronary revascularization in patients with ischemic cardiomyopathy: the scar-to-biphasic model» Am J Cardiol. 2003 Jun 15;91 (12): 1406-9.

15.   Chestuhin V.V., Mironkov A.B., Bljahman F.A., Ostroumov E.N., Kolchanova S.G., Shkljar T.F., Azoev Je.T., Sahovskij S.A. Vlijanie polnoty revaskuljarizacii serdca na funkcional'noe sostojanie miokarda pri ishemicheskoj kardiomiopatii [Influence of completeness of coronary revascularization on the functional state of the myocardium in ischemic cardiomyopathy.]. Vestnik transplantologii i iskusstvennyh organov. 2013: 14(4):55-63 [In Russ].

16.   Bax J.J., Visser F.C., Poldermans D., et al. Time course of functional recovery of stunned and hibernating segments after surgical revascularization. Circulation. 2001; 104(Suppl 1):I314 -8. (АНГИОЛОГИЯ.ру) - портал о диагностике и лечении заболеваний сосудистой системы